Skip to main content
Clinical Trials/ISRCTN49486383
ISRCTN49486383
Completed
未知

A multicentre cohort study of the clinical utility, patient preference and cost benefit of single photon emission computed tomography (SPECT) and positron emission tomography computed tomography (PET-CT) brain imaging in the evaluation and diagnosis of Alzheimer's disease

orthumberland, Tyne and Wear NHS Trust (UK)0 sites100 target enrollmentMay 12, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Subtopic: Dementia
Sponsor
orthumberland, Tyne and Wear NHS Trust (UK)
Enrollment
100
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 12, 2010
End Date
TBD
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
orthumberland, Tyne and Wear NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of probable Alzheimer's disease or probable dementia with Lewy bodies or healthy age matched controls
  • 2\. Aged over 60 years, either sex
  • 3\. Dementia patients to have mild to moderate dementia severity (mini mental state examination \[MMSE] greater than 12\)
  • 4\. Sufficient English to complete cognitive and psychiatric ratings

Exclusion Criteria

  • 1\. Physical disability that would render the patient unable to undergo PET and SPECT scanning
  • 2\. Contraindications to PET or SPECT scanning
  • 3\. Unwillingness to undergo scanning

Outcomes

Primary Outcomes

Not specified

Similar Trials